
Biopharma M&A Activity Jumps 101% in Q1 2025, but Uncertainty Around Trump’s Policies Keeps Big Deals in Check
May 8, 2025
The global biopharmaceutical sector saw a sharp 101% surge in merger and acquisition (M&A) deal value in Q1 2025, reaching $37.7 billion—up from $18.8 billion in Q4 2024—according to GlobalData’s Pharmaceutical Intelligence Center Deals Database. Despite the growth, total deal






